|
|
|||||||||||||
|
|
||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbiology |
1 University of Pecs, Hungary
* To whom correspondence should be addressed. E-mail: bogar{at}clinics.pote.hu.
Accepted 9 November 2005
| Abstract |
|---|
Aims: Early detection of blood stream infection can be lifesaving by initiation of immediate and adequate measures in critically ill patients. However, the results of blood culture tests are usually available only 24 hours after blood sampling. It is obvious that an earlier hint would provide some advantages for critical care patients by initiation of immediate and adequate antibiotic therapy. The aim of this study was to evaluate the ability of leukocyte count, serum procalcitonin (PCT) concentration, erythrocyte sedimentation rate (ESR) and leukocyte antisedimentation rate (LAR) to predict blood culture result in critical care patients.
Methods: LAR indicates the percentage of leukocytes crossing the middle line of blood column upward during one-hour gravity sedimentation. The relevance of the different parameters was estimated by using likelihood-ratio test and area under receiver operating characteristic curves (AUC).
Results: A total of 39 consecutive patients presenting their first febrile episode were investigated prospectively. Twenty-three patients had positive, 16 had negative blood culture results. LAR was significantly higher in bacteremic patients than in non-bacteremic patients (p = 0.001) but leukocyte count, ESR and PCT level failed to present significant differences. Leukocyte count, PCT and ESR yielded low discriminative values with the AUCs of 0.66, 0.64 and 0.52, respectively. LAR provided likelihood-ratio of 3.6 and an AUC of 0.80 (95% CI, 0.64 to 0.95; p = 0.002).
Conclusions: This study suggests that the simple LAR test can predict blood culture results and support urgent treatment decisions in critical care patients at their first febrile episode.
Key Words: bacteremia, erythrocyte sedimentation rate, leukocyte, procalcitonin, severe sepsis
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |